Evaluation of risk factors, primary diagnosis, causes, and outcomes of repeat endoscopic retrograde cholangiopancreatography
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is a minimally invasive endoscopic method that is used for the diagnosis and treatment of pancreaticobiliary diseases. ERCP may have to be performed two or more times, which carries a risk of complications and even death. Various risk factors influence the likelihood of ERCP recurrence. Methods: A retrospective study was conducted at Pauls Stradins Clinical University Hospital. Fifty patients with a history of repeat ERCP were enrolled. The total ERCP count was 122. The total death rate, 30-day postprocedural mortality, laboratory markers, and primary diagnosis were analyzed, and the therapeutic interventions used during ERCP, common bile duct’s diameter, and causes of repeat ERCP were evaluated. Results: The postprocedural 30-day mortality of repeat ERCP was 3.3%, and the overall death rate was 8%. We found a significant difference between the number of repeat ERCPs and exitus letalis (mean = 2.25 vs. mean = 1.37). The most common primary diagnosis for repeat ERCP was choledocholithiasis (64%; n = 32). We found a significant relationship between choledocholithiasis and history of cholecystectomy (P < 0.001) and obesity (P < 0.001). The rate of successful cannulation for ERCP reached 88.5%, with a significant difference between the success of cannulation and bilirubin level (205.64 ± 234.42 μmol/L vs. 58.71 ± 97.65 μmol/L, P = 0.037). The results showed a significant relationship between the success of cannulation and the presence of jaundice (P = 0.014) and periampullary diverticulum (P = 0.017). Conclusion: A greater number of repeated ERCPs carries a higher risk of overall death outcome. The disturbances in laboratory markers (decreased hemoglobin; elevated leucocytes, bilirubin, creatinine, alkaline phosphatase, C-reactive protein) could be a risk factor for negative 30-day postprocedural outcome. The risk factors for repeating ERCP include adiposity, history of cholecystectomy, bilirubin level, jaundice, and periampullary diverticulum.
Abstract
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is a minimally invasive endoscopic method that is used for the diagnosis and treatment of pancreaticobiliary diseases. ERCP may have to be performed two or more times, which carries a risk of complications and even death. Various risk factors influence the likelihood of ERCP recurrence. Methods: A retrospective study was conducted at Pauls Stradins Clinical University Hospital. Fifty patients with a history of repeat ERCP were enrolled. The total ERCP count was 122. The total death rate, 30-day postprocedural mortality, laboratory markers, and primary diagnosis were analyzed, and the therapeutic interventions used during ERCP, common bile duct’s diameter, and causes of repeat ERCP were evaluated. Results: The postprocedural 30-day mortality of repeat ERCP was 3.3%, and the overall death rate was 8%. We found a significant difference between the number of repeat ERCPs and exitus letalis (mean = 2.25 vs. mean = 1.37). The most common primary diagnosis for repeat ERCP was choledocholithiasis (64%; n = 32). We found a significant relationship between choledocholithiasis and history of cholecystectomy (P < 0.001) and obesity (P < 0.001). The rate of successful cannulation for ERCP reached 88.5%, with a significant difference between the success of cannulation and bilirubin level (205.64 ± 234.42 μmol/L vs. 58.71 ± 97.65 μmol/L, P = 0.037). The results showed a significant relationship between the success of cannulation and the presence of jaundice (P = 0.014) and periampullary diverticulum (P = 0.017). Conclusion: A greater number of repeated ERCPs carries a higher risk of overall death outcome. The disturbances in laboratory markers (decreased hemoglobin; elevated leucocytes, bilirubin, creatinine, alkaline phosphatase, C-reactive protein) could be a risk factor for negative 30-day postprocedural outcome. The risk factors for repeating ERCP include adiposity, history of cholecystectomy, bilirubin level, jaundice, and periampullary diverticulum.
참고문헌 (17)
- "Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults" (2023)[URL]
- Siiki A, "ERCP procedures in a Finnish community hospital : a retrospective analysis of 1207 cases", Scand J Surg, 110, pp.45~50 (2012)
- Andriulli A, "Incidence rates of post-ERCP complications : a systematic survey of prospective studies", Am J Gastroenterol, 102, pp.1781~1788 (2007)
- Glomsaker T, "Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography", Br J Surg, 100, pp.373~380 (2013)
- Kapral C, "Quality assessment of endoscopic retrograde cholangiopancreatography : results of a running nationwide Austrian benchmarking project after 5 years of implementation", Eur J Gastroenterol Hepatol, 24, pp.1447~1454 (2012)
- Kienbauer M, "Austrian benchmarking project for ERCP : a 10-year report", Z Gastroenterol, 56, pp.1227~1236 (2018)
- "Endoscopic retrograde cholangiopancreatography (ERCP)technique" (2023)[URL]
- Toros AB, "Evaluation of repeat ERCP : analysis of a four-year experience", J Gastroint Dig Syst, 2, pp.116~ (2012)
- Gurung RB, "Endoscopic retrograde cholangiopancreatography at Dhulikhel hospital : outcome analysis", Kathmandu Univ Med J(KUMJ), 12, pp.55~59 (2014)
- Kharga B, "Obesity not necessary, risk of symptomatic cholelithiasis increases as a function of BMI", J Clin Diagn Res, 10, pp.PC28~PC32 (2016)
- Heitman SJ, "ERCP and mortality", Gastroenterol Hepatol(N Y), 10, pp.752~754 (2014)
- Sobani ZA, "Endoscopic retrograde cholangiopancreatography in nonagenarian patients : is it really safe?", Clin Endosc, 51, pp.375~380 (2018)
- Demir T, "Evaluation of the success and complication rates of endoscopic retrograde cholangiography according to the difficulty of the procedure", Precis Med Sci, 12, pp.4~9 (2023)
- Mariani A, "Prospective evaluation of ERCP performance in an Italian regional database study", Dig Liver Dis, 51, pp.978~984 (2019)
- Sahar N, "The ASGE grading system for ERCP can predict success and complication rates in a tertiary referral hospital", Surg Endosc, 33, pp.448~453 (2019)
- Hoteit M, "A higher bilirubin level is associated with failure of endoscopic stent placement in patients with a pancreatic head mass and biliary obstruction 190", Am J Gastroenterol, 100, pp.S86~ (2005)
- Yue P, "Clinical significance of different periampullary diverticulum classifications for endoscopic retrograde cholangiopancreatography cannulation", World J Gastroenterol, 26, pp.2403~2415 (2020)